European Union law Part 25

European Union law Part 25

 

342

IMPLEMENTING ENVIRONMENTAL LAW IN THE EUROPEAN UNION: LESSONS FROM THE BATHING WATER DIRECTIVE
Luke W. Goodrich
Georgetown International Environmental Law Review
Volume 16, Number 2, Winter 2004 p.301

LAW JOURNAL / LAW REVIEW

343

European Environmental Law and the Constitution
Alexandre Kiss
Pace Environmental Law Review
Volume 21, Number 1, Symposium Edition 2003 p.103

LAW JOURNAL / LAW REVIEW

The author describes how the European Union sought to institute environmental protection through the development of the constitution and the rights it guarantees such as the right to a healthy environment.

344

European Opposition to Exclusive Control Over Predictive Breast Cancer Testing and the Inherent Implications for U.S. Patent Law and Public Policy: A Case Study of the Myriad Genetics’ BRCA Patent Controversy
Jordan Paradise
Food and Drug Law Journal
Volume 59, Issue 1, 2004 p.133-154

LAW JOURNAL / LAW REVIEW

Controversy over gene Patents has arisen due to a variety of issues, including their relatively recent arrival into the patent realm, their grant of exclusivity over specific sequences of human genes, and their effect on research and diagnosis. These issues ultimately reflect both legal factors, dealing directly with the application of patent laws-and policy factors-implicating problems of access, cost, and quality in both the patient realm and the research setting. Because many gene Patents either directly claim or include genes and/or the corresponding proteins that are essential to genetic diagnosis, a grant of exclusivity may hinder both healthcare and the advancement of scientific technology. There currently is an unparalleled legal challenge underway in the European Union regarding a number of human gene patents held by Myriad Genetics, a U.S. corporation, for sequences of two genes, BRCA1 and BRCA2, mutations in which indicate a predisposition to breast cancer. Specifically, the most recent opposition challenges the patent as not fulfilling relevant provisions in the European patent law, as well as impeding heathcare and scientific discovery. This article addresses the European controversy over the BRCA1 gene patent and offers potential mechanisms to resolve similar legal and policy concerns in the United States.

345

Human rights and the future of extradition in the European Union: Implications of recent case law in the United Kingdom, France and Spain
Susie Alegre
ERA Forum
Volume 4, Number 4, December 2003 p.63

LAW JOURNAL / LAW REVIEW

346

International Trade and Economic Law and the European Union
O’KEEFFE, SIàšN
King’s Law Journal
Volume 14, issue 2, 2003 p.309-316

LAW JOURNAL / LAW REVIEW

347

The Status of the Law on SLaw Journal / Law Reviewk Companies in Central and Eastern-Europe: Facing the Challenge to Enter the European Union and Implement European Company Law
Marie-Agnes Arlt, Cécile Bervoets, Kristoffel Grechenig and Suanne Kalss
European Business Organization Law Review
Volume 4, Issue 2, October 2003 p.245-272

LAW JOURNAL / LAW REVIEW

348

Conflict of Law Rules in Company Law after àœberseering: An Economic and Comparative Analysis of the Allocation of Policy Competence in the European Union
Stefano Lombardo
European Business Organization Law Review
Volume 4, Issue 2, October 2003 p.301-336

LAW JOURNAL / LAW REVIEW

349

Interlocking Legal Orders in the European Union and Comparative Law
Koen Lenaerts
International and Comparative Law Quarterly
Volume 52, Number 4, October 2003 p.873-906

LAW JOURNAL / LAW REVIEW

350

Current Developments: European Union law
International and Comparative Law Quarterly
Volume 52, Number 4, October 2003

LAW JOURNAL / LAW REVIEW

351

FINDING FUNDAMENTAL FAIRNESS: PROTECTING THE RIGHTS OF HOMOSEXUALS UNDER EUROPEAN UNION ACCESSION LAW
San Diego International Law Journal
Volume 4, 2003 p.437

LAW JOURNAL / LAW REVIEW

 

Conclusion

Notes

See Also

References and Further Reading

About the Author/s and Reviewer/s

Author: international

Mentioned in these Entries

European Union law, Patents.


Posted

in

, ,

by

Tags:

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *